Start with treatment for skin cancer at an early syage. Know the signs and symptoms and get treated at the earliest to prevent complications of ... Jan 14
Latest news updates... Oct 26
Do you know sunscreen is better at protecting your skin than a full sleeve cotton dress? Read to find out more.... Oct 05
FDA News Update... Aug 05
... Jul 22
... Jul 17
Dr.Vandana shares important information about albinism and its types. She also mentions the tips for skincare for patients with albinism. A must-read article ... Jul 03
Albinism is a hereditary condition. The body fails to produce melanin that affects skin, hair, and eyes. As there is no cure, patients are likely ... Jun 29
Significantly improves progression-free Survival vs. Opdivo (nivolumab) in patients... May 22
Surgery is currently the most common treatment option for the treatment of NMSC which often carry significant cutaneous adverse events, risk of scar, infection, bleeding ... Apr 27
... Apr 07
... Apr 05
... Mar 30
The antibody is indicated for patients with previously untreated Metastatic or unresectable melanoma... Mar 27
Approval comes after Failure of at Least Two Lines of Prior Systemic Therapy... Feb 22
The product candidate has received multiple IND approvals from both the US FDA and Chinese NMPA... Jan 18
Revive Therapeutics to acquire the full rights to PharmaTher Inc.’s intellectual property pertaining to psilocybin... Dec 22
The primary endpoint of this trial was to evaluate patients for complete histological clearance of the tumour cells within the treated isSCC lesion... Dec 21
OncoBeta, announced today that the Rhenium-SCT (Rhenium-188 paste) has been registered on the Australian Register of Therapeutic Goods (ARTG), which is the formal ... Dec 19
PharmaTher Inc collaborates with Revive Therapeutics for psilocybin and panaceAI psychedelic discovery AI platform ... Nov 19
... Nov 12
LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
European Commission decision marks the first time a dual immunotherapy with limited chemotherapy is approved for patients with non-small cell lung cancer in the ... Nov 09
European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer.... Nov 02
-Advertisements-
Saturday, May 21, 2022
